BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17369457)

  • 21. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure.
    Ramchandra R; Hood SG; Denton DA; Woods RL; McKinley MJ; McAllen RM; May CN
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):924-8. PubMed ID: 19136635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostaglandins in determining the increased cardiac sympathetic nerve activity in ovine sepsis.
    Booth LC; Ramchandra R; Calzavacca P; May CN
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(1):R75-81. PubMed ID: 24789991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac sympathetic innervation via middle cervical and stellate ganglia and antiarrhythmic mechanism of bilateral stellectomy.
    Irie T; Yamakawa K; Hamon D; Nakamura K; Shivkumar K; Vaseghi M
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H392-H405. PubMed ID: 28011590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central exogenous nitric oxide decreases cardiac sympathetic drive and improves baroreflex control of heart rate in ovine heart failure.
    Ramchandra R; Hood SG; May CN
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(3):R271-80. PubMed ID: 24848361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep.
    Watson AM; Mogulkoc R; McAllen RM; May CN
    Am J Physiol Regul Integr Comp Physiol; 2004 Jun; 286(6):R1051-6. PubMed ID: 14751846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.
    Ramchandra R; Hood SG; Watson AM; Allen AM; May CN
    Hypertension; 2012 Mar; 59(3):634-41. PubMed ID: 22311902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The low frequency power of heart rate variability is neither a measure of cardiac sympathetic tone nor of baroreflex sensitivity.
    Martelli D; Silvani A; McAllen RM; May CN; Ramchandra R
    Am J Physiol Heart Circ Physiol; 2014 Oct; 307(7):H1005-12. PubMed ID: 25063795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in heart rate precedes episodes of ventricular tachycardia and ventricular fibrillation in patients with implantable cardioverter defibrillators: analysis of spontaneous ventricular tachycardia database.
    Nemec J; Hammill SC; Shen WK
    Pacing Clin Electrophysiol; 1999 Dec; 22(12):1729-38. PubMed ID: 10642125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic myocardial infarction is a substrate for bradycardia-induced spontaneous tachyarrhythmias and sudden death in conscious animals.
    Killingsworth CR; Walcott GP; Gamblin TL; Girouard SD; Smith WM; Ideker RE
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):189-97. PubMed ID: 16533257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin receptor--a blockade decreases ventricular arrhythmias after myocardial infarction in rats.
    Baltogiannis GG; Tsalikakis DG; Mitsi AC; Hatzistergos KE; Elaiopoulos D; Fotiadis DI; Kyriakides ZS; Kolettis TM
    Cardiovasc Res; 2005 Sep; 67(4):647-54. PubMed ID: 15907816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respective role of sympathetic tone and of cardiac pauses in the genesis of 62 cases of ventricular fibrillation recorded during Holter monitoring.
    Leclercq JF; Maisonblanche P; Cauchemez B; Coumel P
    Eur Heart J; 1988 Dec; 9(12):1276-83. PubMed ID: 3229422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality.
    Schwenke DO; Tokudome T; Kishimoto I; Horio T; Shirai M; Cragg PA; Kangawa K
    Endocrinology; 2008 Oct; 149(10):5172-6. PubMed ID: 18599547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic abnormalities and ventricular tachyarrhythmias after myocardial infarction.
    Hyytinen-Oinas MK; Ylitalo K; Karsikas M; Seppänen T; Raatikainen MJ; Uusimaa P; Huikuri HV; Perkiömäki JS
    Scand Cardiovasc J; 2010 Feb; 44(1):15-23. PubMed ID: 19479631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation.
    Oikarinen L; Viitasalo M; Toivonen L
    Am J Cardiol; 1998 Mar; 81(6):694-7. PubMed ID: 9527076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve sprouting and sudden cardiac death.
    Cao JM; Chen LS; KenKnight BH; Ohara T; Lee MH; Tsai J; Lai WW; Karagueuzian HS; Wolf PL; Fishbein MC; Chen PS
    Circ Res; 2000 Apr; 86(7):816-21. PubMed ID: 10764417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    Mehta RH; Starr AZ; Lopes RD; Hochman JS; Widimsky P; Pieper KS; Armstrong PW; Granger CB;
    JAMA; 2009 May; 301(17):1779-89. PubMed ID: 19417195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urocortin 2 induces potent long-lasting inhibition of cardiac sympathetic drive despite baroreflex activation in conscious sheep.
    Charles CJ; Jardine DL; Rademaker MT; Richards AM
    J Endocrinol; 2010 Feb; 204(2):181-9. PubMed ID: 19914944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct measurement of cardiac sympathetic efferent nerve activity during dynamic exercise.
    Tsuchimochi H; Matsukawa K; Komine H; Murata J
    Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1896-906. PubMed ID: 12384467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous nerve activity and spontaneous ventricular arrhythmias in ambulatory dogs.
    Doytchinova A; Patel J; Zhou S; Chen LS; Lin H; Shen C; Everett TH; Lin SF; Chen PS
    Heart Rhythm; 2015 Mar; 12(3):612-620. PubMed ID: 25460171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baroreflex sensitivity, but not heart rate variability, is reduced in patients with life-threatening ventricular arrhythmias long after myocardial infarction.
    De Ferrari GM; Landolina M; Mantica M; Manfredini R; Schwartz PJ; Lotto A
    Am Heart J; 1995 Sep; 130(3 Pt 1):473-80. PubMed ID: 7661063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.